Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Biosimulation Companies

ID: MRFR/HC/7108-HCR
200 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Biosimulation involves the use of computer-based models to simulate biological processes, drug interactions, and various aspects of physiological systems. It is widely utilized in pharmaceutical research and development to predict the behavior of drugs, study disease mechanisms, and optimize treatment strategies.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biosimulation Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)15.9%
2025 Market SizeUSD 4.25 Billion
2035 Market SizeUSD 18.71 Billion
Key Players
Certara
Simulations Plus
Dassault Systèmes
Schrödinger
Advanced Chemistry Development
Chemical Computing Group
Opportunities
  • Regulatory-Grade Virtual Control Arms
  • Emerging-Market CRO Partnerships
  • Model Libraries as a Monetisable Asset

Top Industry Leaders in the Biosimulation Market

Biosimulation Key Companies
 
Latest Biosimulation Companies Update:

Simulations Plus acquires Immunetrics: This strengthens Simulations Plus' quantitative systems pharmacology (QSP) expertise and expands its reach in oncology, immunology, and autoimmune diseases.

Certara partners with Infosys: This collaboration aims to integrate Certara's biosimulation software with Infosys' life sciences cloud platform, offering more accessible and scalable modeling solutions.

Thermo Fisher Scientific and Simulia collaborate: This partnership focuses on developing digital twins for bioreactors, allowing for real-time monitoring and optimization of biomanufacturing processes.

Certara unveils SimCyp Pediatric 5.0: This latest version of their popular pharmacokinetic (PK) simulation platform features an expanded pediatric database and new modeling capabilities for pediatric drug development.

Physiomics launches the Virtual Tumor Suite 5.0: This upgraded software offers improved tumor growth and treatment response prediction for personalized medicine applications.

Advanced Chemistry Labs introduces the NMRView® Exchange software: This innovative tool automates the analysis of biomolecular interactions using nuclear magnetic resonance (NMR) spectroscopy.

List of Biosimulation Key companies in the market
  • Dassault Systèmes (France)
  • Certara USA, Inc. (US)
  • Simulation Plus (US)
  • Schrödinger (US)
  • Chemical Computing Group (Canada)
  • Physiomics (UK)
  • In Silico Biosciences (US)
  • Advanced Chemistry Development, Inc. (Canada)
  • Genedata AG (Switzerland)
  • Nuventra Pharma (US)
  • Evidera (US)
  • Leadinvent Technologies (India)
  • LeadScope, Inc. (US)
  • Rosa (US)
  • INOSIM Software GmbH (Germany)
Get In-Depth Insights on Key Biosimulation Companies